
Keywords: کارسینوم متاستاتیک کولورکتال; ANOVA; analysis of variance; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; mCRC; metastatic colorectal carcinoma; SHAPD; systemic-hepatic artery pressure difference; SIS; Surefire Infusion System; TARE; tr